EUVIMEDEUVIMED entdecken
FallberichtOpen Access

Leptomeningeal Carcinomatosis During Dose-Reduced Osimertinib Therapy in Epidermal Growth Factor Receptor (EGFR) L858R-Mutated Lung Adenocarcinoma: A Case Report

Yu Tsukasa, Yukihiro Sugimoto, Takayuki Yamamoto, Ryota Aoki, Hirofumi Nakano

Cureus · 28.04.2026

DOI: 10.7759/cureus.107914 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Cureus, erschienen am 28.04.2026. Verfasst von Yu Tsukasa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory Medicine, Fukuoka Seisyukai Hospital, Fukuoka, JPN. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

egfr tyrosine kinase inhibitorsegfr-mutant lung adenocarcinomaleptomeningeal carcinomatosisnon-small cell lung cancerthrombocytopenia

Autor:innen und Institutionen

  • Department of Respiratory Medicine, Fukuoka Seisyukai Hospital, Fukuoka, JPN.

Zitieren

APA

Tsukasa, Y., Sugimoto, Y., Yamamoto, T., Aoki, R., & Nakano, H. (2026). Leptomeningeal Carcinomatosis During Dose-Reduced Osimertinib Therapy in Epidermal Growth Factor Receptor (EGFR) L858R-Mutated Lung Adenocarcinoma: A Case Report. Cureus. https://doi.org/10.7759/cureus.107914

Vancouver

Tsukasa Y, Sugimoto Y, Yamamoto T, Aoki R, Nakano H. Leptomeningeal Carcinomatosis During Dose-Reduced Osimertinib Therapy in Epidermal Growth Factor Receptor (EGFR) L858R-Mutated Lung Adenocarcinoma: A Case Report. Cureus. 2026. doi:10.7759/cureus.107914

BibTeX
@article{Tsukasa2026,
  author = {Tsukasa, Yu and Sugimoto, Yukihiro and Yamamoto, Takayuki and Aoki, Ryota and Nakano, Hirofumi},
  title = {Leptomeningeal Carcinomatosis During Dose-Reduced Osimertinib Therapy in Epidermal Growth Factor Receptor (EGFR) L858R-Mutated Lung Adenocarcinoma: A Case Report},
  journal = {Cureus},
  year = {2026},
  doi = {10.7759/cureus.107914}
}
Kostenlos starten →